OnKure Therapeutics Inc. (OKUR)
NASDAQ: OKUR
· Real-Time Price · USD
2.53
-0.14 (-5.24%)
At close: Aug 15, 2025, 3:59 PM
2.44
-3.63%
After-hours: Aug 15, 2025, 07:38 PM EDT
OnKure Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
Cash & Equivalents | 83.37M | 96.66M | 110.76M | 60.69M | 18.63M | 19.25M | 29.88M | 11.74M | 9.08M |
Short-Term Investments | n/a | n/a | n/a | 15.98M | 40.7M | 62.46M | n/a | 113.88M | 133.6M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 116K | 109K | 109K | 147K | 49K | 51K | 58K | 81K | 79K |
Receivables | n/a | n/a | n/a | n/a | 2.04M | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.18M | 1.51M | n/a | 331K | 656K | 739K | n/a | 3.16M | 3.64M |
Total Current Assets | 84.55M | 98.17M | 113M | 77M | 23.8M | 22.71M | 33.77M | 128.77M | 146.32M |
Property-Plant & Equipment | 1.4M | 1.6M | 1.79M | 499K | 1.63M | 1.77M | 1.91M | 1.53M | 1.64M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.52M | 1.71M | 1.9M | 646K | 1.68M | 1.82M | 1.97M | 1.62M | 1.72M |
Total Assets | 86.07M | 99.88M | 114.91M | 77.64M | 25.47M | 24.53M | 35.73M | 130.39M | 148.04M |
Account Payables | 2.38M | 2.34M | 2.97M | 237K | 8.26M | 3.62M | 3.42M | 2.47M | 1.83M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 556K | 546K | 536K | 286K | 331K | 331K | 208K | 325K | 318K |
Other Current Liabilities | 7.04M | 834K | 2.64M | 2.08M | 1.38M | 256K | 1.46M | 6.93M | 9.07M |
Total Current Liabilities | 7.6M | 8.79M | 10.53M | 3.25M | 12.98M | 5.55M | 7.29M | 13.56M | 13.74M |
Long-Term Debt | 267K | n/a | n/a | n/a | 5.86M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 40K | 40K | n/a | n/a | 129.85M | 129.82M | 129.82M | 1.07M | 876K |
Total Long-Term Liabilities | 307K | 449K | 549K | 379K | 136.07M | 130.24M | 130.29M | 1.88M | 1.77M |
Total Liabilities | 7.9M | 9.23M | 11.08M | 3.63M | 149.05M | 135.79M | 137.58M | 15.44M | 15.51M |
Total Debt | 823K | 955K | 1.08M | 665K | 6.43M | 624K | 674K | 1.14M | 1.22M |
Common Stock | 1K | 1K | 1K | n/a | 1K | 1K | n/a | 3K | 3K |
Retained Earnings | -186.04M | -170.65M | -154.72M | -235.95M | -125.73M | -111.59M | -102.05M | -190.52M | -171.32M |
Comprehensive Income | n/a | n/a | n/a | 2K | -13K | -12K | n/a | -21K | -31K |
Shareholders Equity | 78.17M | 90.65M | 103.83M | 74.02M | -123.58M | -111.26M | -101.84M | 114.94M | 132.53M |
Total Investments | n/a | n/a | n/a | 15.98M | 40.7M | 62.46M | n/a | 113.88M | 133.6M |